Patient Characteristics and Transduction Data
Patient . | Age/Sex . | Cell Source . | Vector . | CD34 Cells . | CFU-C Transduction Efficiency %* . | Transplant Date . | Status . |
---|---|---|---|---|---|---|---|
. | . | . | . | Infused/kg . | . | . | . |
. | . | . | . | (millions) . | . | . | . |
6H | 57/M | PB | G1Na | 1.46 | 19 | 6/20/95 | Alive/CR |
MM 1 | PB | None | 9.05 | ||||
BM | LNL6 | 0.20 | 8 | ||||
BM | None | 0.81 | |||||
6H | 44/M | PB | G1Na | 0.08 | >1 | 4/7/94 | Alive/PR |
MM 2 | PB | None | 0.80 | ||||
BM | LNL6 | 0.75 | ND | ||||
BM | None | 0.75 | |||||
6H | 54/M | PB | G1Na | 0.01 | 1 | 11/18/94 | Alive/PR |
MM 3 | PB | None | 1.63 | ||||
BM | LNL6 | 0.07 | 0 | ||||
BM | None | 0.02 | |||||
6H | 45/F | PB | LNL6 | 4.61 | >0 | 10/11/94 | Alive/CR |
BC 4 | PB | None | 19.29 | ||||
BM | G1Na | 0.18 | 2 | ||||
BM | None | 4.00 | |||||
6H | 53/F | PB | LNL6 | 0.80 | ND | 10/12/95 | Alive/PD Day 111 |
BC 5 | PB | None | 3.40 | ||||
BM | G1Na | 0.11 | ND | ||||
BM | None | 1.00 | |||||
ST | 46/M | PB | LNL6 | 0.07 | 20 | 6/24/94 | Alive/PR |
MM 1 | PB | None | 1.03 | ||||
BM | G1Na | 0.00 | 2 | ||||
BM | None | 0.36 | |||||
ST | 48/M | PB | G1Na | 1.12 | 0 | 6/10/94 | Alive/PR |
MM 2 | PB | None | 27.55 | ||||
BM | LNL6 | 0.15 | 10 | ||||
BM | None | 1.69 | |||||
ST | 49/F | PB | LNL6 | 0.09 | ND | 2/29/96 | Alive/PR |
BC 3 | PB | None | 0.72 | ||||
BM | G1Na | 0.18 | 30 | ||||
BM | None | 6.63 | |||||
ST | 36/F | PB | G1Na | 0.32 | 36 | 3/12/96 | Alive/PD Day 123 |
BC 4 | PB | None | 1.10 | ||||
BM | LNL6 | 0.37 | ND | ||||
BM | None | 4.31 |
Patient . | Age/Sex . | Cell Source . | Vector . | CD34 Cells . | CFU-C Transduction Efficiency %* . | Transplant Date . | Status . |
---|---|---|---|---|---|---|---|
. | . | . | . | Infused/kg . | . | . | . |
. | . | . | . | (millions) . | . | . | . |
6H | 57/M | PB | G1Na | 1.46 | 19 | 6/20/95 | Alive/CR |
MM 1 | PB | None | 9.05 | ||||
BM | LNL6 | 0.20 | 8 | ||||
BM | None | 0.81 | |||||
6H | 44/M | PB | G1Na | 0.08 | >1 | 4/7/94 | Alive/PR |
MM 2 | PB | None | 0.80 | ||||
BM | LNL6 | 0.75 | ND | ||||
BM | None | 0.75 | |||||
6H | 54/M | PB | G1Na | 0.01 | 1 | 11/18/94 | Alive/PR |
MM 3 | PB | None | 1.63 | ||||
BM | LNL6 | 0.07 | 0 | ||||
BM | None | 0.02 | |||||
6H | 45/F | PB | LNL6 | 4.61 | >0 | 10/11/94 | Alive/CR |
BC 4 | PB | None | 19.29 | ||||
BM | G1Na | 0.18 | 2 | ||||
BM | None | 4.00 | |||||
6H | 53/F | PB | LNL6 | 0.80 | ND | 10/12/95 | Alive/PD Day 111 |
BC 5 | PB | None | 3.40 | ||||
BM | G1Na | 0.11 | ND | ||||
BM | None | 1.00 | |||||
ST | 46/M | PB | LNL6 | 0.07 | 20 | 6/24/94 | Alive/PR |
MM 1 | PB | None | 1.03 | ||||
BM | G1Na | 0.00 | 2 | ||||
BM | None | 0.36 | |||||
ST | 48/M | PB | G1Na | 1.12 | 0 | 6/10/94 | Alive/PR |
MM 2 | PB | None | 27.55 | ||||
BM | LNL6 | 0.15 | 10 | ||||
BM | None | 1.69 | |||||
ST | 49/F | PB | LNL6 | 0.09 | ND | 2/29/96 | Alive/PR |
BC 3 | PB | None | 0.72 | ||||
BM | G1Na | 0.18 | 30 | ||||
BM | None | 6.63 | |||||
ST | 36/F | PB | G1Na | 0.32 | 36 | 3/12/96 | Alive/PD Day 123 |
BC 4 | PB | None | 1.10 | ||||
BM | LNL6 | 0.37 | ND | ||||
BM | None | 4.31 |
Bold type indicates that all mononuclear cells, not just CD34+ cells, were infused.
Abbreviations: MM, multiple myeloma; BC, breast cancer; PR, partial remission; CR, complete remission; PD, progressive disease; CFU-C, colony-forming unit cell.
% Neomycin resistant CFU-C assayed at the end of transduction.